Cardiac Prosthetic Devices Market Size, Share, Growth 2032
IMARC Group, a leading market research company, has recently released a report titled “Cardiac Prosthetic Devices Market Report by Product Type (Valves, Pacemakers, Implantable Pacemakers, External Pacemakers, and Others), End-User (Hospitals, Clinics and Cardiac Centers, Ambulatory Surgical Centers, and Others), and Region 2024-2032”. The study provides a detailed analysis of the industry, including the global cardiac prosthetic devices market share, trends, size, and industry growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global cardiac prosthetic devices market size reached US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.
Request to Get the Sample Report:
https://www.imarcgroup.com/cardiac-prosthetic-devices-market/requestsample
What are Cardiac Prosthetic Devices?
Cardiac prosthetic devices refer to
medical instruments designed to replace or support the function of the heart.
These devices are crucial in managing cardiac conditions and have significantly
advanced medical treatment. Common cardiac prosthetic devices include
artificial heart valves, ventricular assist devices (VADs), and total
artificial hearts. Artificial heart valves are used to replace damaged or
malfunctioning natural valves, ensuring proper blood flow within the heart.
Ventricular assist devices are mechanical pumps that aid a weakened heart in
pumping blood. Total artificial hearts, on the other hand, temporarily replace
the entire heart to support patients awaiting heart transplants.
Cardiac Prosthetic Devices Market
Trends
The increasing prevalence of cardiovascular
diseases, such as heart valve disorders and heart failure, represents one of
the key factors driving the growth of the market across the globe. As the
global population ages and lifestyles change, the incidence of these conditions
continues to rise, creating a substantial demand for cardiac prosthetic
devices. Technological advancements are significantly improving the design and
performance of cardiac prosthetic devices. These innovations include the
development of biocompatible materials, minimally invasive surgical techniques,
and advanced imaging modalities. These innovations enhance device durability
and patient outcomes. The aging population is more susceptible to heart-related
issues, and as this demographic group expands, so does the demand for cardiac
prosthetic devices.
This factor is particularly relevant
in developed nations where the elderly population is a significant portion of
the total population. The market is also driven by the rising patient awareness
about their health. They often seek treatments that offer a better quality of
life. Consequently, there is a growing demand for prosthetic devices that
provide improved performance, durability, and quality of life. Other factors,
such as increasing healthcare spending, and the rise of medical tourism are
creating a positive outlook for the market across the globe.
Cardiac Prosthetic Devices Market Report
Segmentation:
Breakup by Product Type:
Valves
·
Mechanical Valve
·
Tissue Valve
·
Stented Tissue Valve
·
Stentless Tissue Valve
·
Transcatheter Valve
Pacemakers
Implantable Pacemakers
·
Single-Chamber Battery Pacemaker
·
Dual-Chamber Battery Pacemaker
·
Triple-Chamber Battery Pacemaker
External Pacemakers
Others
Breakup by End-User:
·
Hospitals, Clinics and Cardiac Centers
·
Ambulatory Surgical Centers
·
Others
Breakup
by Region:
·
North
America
·
Asia
Pacific
·
Europe
·
Latin
America
·
Middle East and Africa
The competitive landscape of cardiac prosthetic devices market size has been studied in the report with the detailed profiles of the key players operating in the market
Some of These Key Players Include:
·
Abbott Laboratories
·
Biotronik
·
Boston Scientific Corporation
·
Edwards Lifesciences Corporation
·
Lepu Medical Technology Co. Ltd.
·
Medtronic Inc.
·
Meril Life Sciences Pvt. Ltd.
·
Siemens Healthcare GmbH
·
Sorin Group
·
St. Jude Medical Inc.
Ask Analyst for Customized Report:
https://www.imarcgroup.com/request?type=report&id=2037&flag=C
Key Highlights of the Report:
·
Market Performance
(2018-2023)
·
Market Outlook
(2024-2032)
·
Market Trends
·
Market Drivers and
Success Factors
·
Impact of COVID-19
·
Value Chain Analysis
If you need specific information that is not currently within the scope
of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management
strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most
critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic
and technological developments for business leaders in pharmaceutical,
industrial, and high technology organizations. Market forecasts and industry
analysis for biotechnology, advanced materials, pharmaceuticals, food and
beverage, travel and tourism, nanotechnology and novel processing methods are
at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th
St
Brooklyn,
NY 11249, USA
Website: imarcgroup.com
Email:
sales@imarcgroup.com
Americas:
+1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
댓글
댓글 쓰기